View source for Cardiomyopathy secondary prevention
Jump to navigation
Jump to search
You do not have permission to edit this page, for the following reason:
You can view and copy the source of this page.
Templates used on this page:
- Template:AE (view source)
- Template:CALISKAN, K. , SZILI‐TOROK, T. , THEUNS, D. A., KARDOS, A. , GELEIJNSE, M. L., BALK, A. H., VAN DOMBURG, R. T., JORDAENS, L. and SIMOONS, M. L. (2011), Indications and Outcome of Implantable Cardioverter‐Defibrillators for Primary and Secondary Prophy (view source)
- Template:CMG (view source)
- Template:Cardiomyopathy (view source)
- Template:Column-width (view source)
- Template:EdzelCo (view source)
- Template:Main other (view source)
- Template:Reflist (view source)
- Template:WH (view source)
- Template:WS (view source)
- Template:WikiDoc CMG (view source)
- Module:Check for unknown parameters (view source)
Return to Cardiomyopathy secondary prevention.